About

Rosalynn M. Nazarian received her M.D. degree from the Chobanian & Avedisian School of Medicine (2003). She trained in Anatomic & Clinical Pathology, Massachusetts General Hospital, Boston MA (2004-08) and in Dermatopathology, Harvard Combined Program (2008-09).

She was an Associate Professor of Pathology at Harvard Medical School and Dermatopathologist at Massachusetts General Hospital until December 2025. She brings a background that bridges biomedical engineering and medicine, applying scientific insight to clinical dermatopathology.

She served as Associate Program Director for the Mass General Brigham Dermatopathology Fellowship and as Vice Chair of the Harvard Medical School Faculty Council, and was honored with the Inaugural Professor Elizabeth Van Cott, MD, Award for Mentorship in Pathology.

With over 140 peer-reviewed publications, Dr. Nazarian serves as Senior Associate Editor for the Journal of Cutaneous Pathology and Vice Chair of the Standards of Practice Committee of the American Society of Dermatopathology. She led the Diversity Committee of the Department of Pathology and is a member of the Global Education and Clinical Innovation Collaborative at Massachusetts General Hospital, where she volunteered as a Dermatopathology Consultant, providing telepathology support to physicians in Armenia, Kenya, Tanzania, Uganda, and Haiti.

 

  • Specialties

    Melanocytic lesions, Squamous epithelial neoplasms and pigmentary disorders.

  • Administrative Title

    Jag Bhawan Professor of Dermatology and Pathology, Head of the Dermatopathology Section, Director, Skin Pathology Laboratory & Dermatopathology training programs, Department of Dermatology, Boston University School of Medicine.

  • Residency

    Massachusetts General Hospital, Boston, 2008

  • Fellowship

    Mass General Brigham/Harvard Combined Program, Boston, 2009

  • Research Interests

    Cutaneous pathology of complex medical dermatoses, with a focus on signaling pathway activation in wound repair, calciphylaxis, scleroderma, and adverse drug reactions

  • Education

    Medical School: BU Chobanian and Avedisian School of Medicine, Boston, 2003